The Leader in Neurological Research and Clinical Studies.

Alzheimer’s with Mild Cognitive Impairment

ENROLL IN THE MILD COGNITIVE IMPAIRMENT ALZHEIMER'S RESEARCH STUDY

About the Study

If your loved one is suffering from Alzheimer’s disease, there is hope. Medical and non-profit organizations are working tirelessly to find treatments and a cure. Part of the process of discovering effective treatments for Alzheimer’s are clinical trials. These research studies and clinical trials are separated into phases, and are offered to patients with Alzheimer’s after pre-clinical trials and early phase studies are completed. 

An Alzheimer’s clinical trial at the Fort Wayne Neurological Center offers patients the opportunity to receive care from the nation’s leading neurologists, and includes treatment and continued monitoring at no cost to the patient, with expenses for time and travel potentially reimbursed as well. 

The Center for Neurological research is currently enrolling patients for the Mild Cognitive Impairment Alzheimer’s study. If your loved one is suffering from Alzheimer’s disease, please review the following research study qualifications and fill out the form below to see if you are eligible for this study. 

Inclusion Criteria

You may qualify for the Alzheimer's with Mild Cognitive Impairment study if you must meet the following criteria.

Condition: Probable Alzheimer’s Disease (AD) Dementia

Age: 50-90

Gender: Male or Female

  • Meets National Institute on Aging/Alzheimer’s Association (NIAAA) core clinical criteria for probable Alzheimer’s Disease Dementia or prodromal Alzheimer’s Disease 
  • Evidence of Alzheimer’s Disease pathological process through CSF or amyloid PET scan
  • Demonstrated abnormal memory function
  • Mini-Mental State Examination (MMSE) score greater than or equal to 22.
  • Clinical dementia rating-global score (CDR-GS) of 0.5 or 1.0
  • Availability of a reliable study partner who accepts to participate in study procedures throughout the duration of a 2 year study
  • If receiving symptomatic Alzheimer’s Disease medications, the dosing regimen must be stable for 3 months prior to baseline and until randomization.

Exclusion Criteria

If some of the following apply, you MAY NOT qualify for this study.

  • Any evidence of a condition other than Alzheimer’s Disease that may affect cognition
  • History of schizophrenia, schizoaffective disorder, major depression, or bipolar disorder
  • History or presence of clinically evident systemic vascular disease that in the opinion of the investigator has the potential to affect cognitive function
  • History or presence of clinically evident cerebrovascular disease
  • Patients with evidence of folic acid deficiency
  • Alcohol and/or substance abuse in the past 2 years
  • Relevant brain hemorrhage, bleeding disorder and cerebrovascular abnormalities
  • Unstable or clinically significant cardiovascular, kidney or liver disease
  • Uncontrolled hypertension

Principle Investigator

Neurologist Leading The Study

See if you qualify for this study

Name *

Email *

Phone *

Please Select your Study of Interest *

Message

Team of Neurology Research Coordinators & Doctors

Additional Resources

Resources for Alzheimer Patients and Caregivers

We know that an Alzheimer’s diagnosis is a challenging prospect to face. We’re here to help. We want to provide you with every available resource to equip and help you on your health journey. We’ve created a list of organizations that are actively working to find answers, provide information, discover new treatments, and who are relentlessly advocating on your behalf.

Their mission is to rid the world of Alzheimer’s disease. It’s ambitious, but they are actively pursuing every avenue to accomplish it. Armed with care and support for families affected by Alzheimer’s, funding research, and leading the way with advocacy, Alzheimer’s Association is making an impact against Alzheimer’s Disease Dementia. They have a 24/7 hotline with clinicians who can give information and referrals to people affected by Alzheimer’s. 

Visit Website: https://alz.org

Dementia Care Central is an educational resource for anyone affected by dementia, Alzheimer’s included.  They offer resources for learning more about dementia and Alzheimer’s, and include support resources for caregivers of dementia patients.

Visit Website: dementiacarecentral.com

Alzheimer’s Drug Discovery Foundation is a resource entirely committed to finding treatments and cures for Alzheimer’s. They offer patients and caregivers the latest information in research, drug discovery, and medical advances in Alzheimer’s treatments.

Visit Website: https://www.alzdiscovery.org

ALZ Connected is a free online forum for anyone affected by Alzheimer’s Disease. They offer connections that allow people to share their personal experiences with one another to better support those who are affected by Alzheimers’. Their online community helps people know they are not alone in their battle against Alzheimer’s.

Visit Website: https://www.alzconnected.org